Annual Retained Earnings
-$441.43 M
-$22.93 M-5.48%
31 December 2023
Summary:
Cidara Therapeutics annual retained earnings is currently -$441.43 million, with the most recent change of -$22.93 million (-5.48%) on 31 December 2023. During the last 3 years, it has fallen by -$106.73 million (-31.89%). CDTX annual retained earnings is now -31207.16% below its all-time high of -$1.41 million, reached on 31 December 2013.CDTX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$558.95 M
-$15.98 M-2.94%
30 September 2024
Summary:
Cidara Therapeutics quarterly retained earnings is currently -$558.95 million, with the most recent change of -$15.98 million (-2.94%) on 30 September 2024. Over the past year, it has dropped by -$134.66 million (-31.74%). CDTX quarterly retained earnings is now -4101.38% below its all-time high of -$13.30 million, reached on 31 December 2014.CDTX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CDTX Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -5.5% | -31.7% |
| 3 y3 years | -31.9% | -55.1% |
| 5 y5 years | -101.8% | -127.4% |
CDTX Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -31.9% | at low | -55.1% | at low |
| 5 y | 5 years | -101.8% | at low | -127.4% | at low |
| alltime | all time | <-9999.0% | at low | -4101.4% | at low |
Cidara Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$558.95 M(+2.9%) |
| June 2024 | - | -$542.97 M(+20.2%) |
| Mar 2024 | - | -$451.76 M(+2.3%) |
| Dec 2023 | -$441.43 M(+5.5%) | -$441.43 M(+4.0%) |
| Sept 2023 | - | -$424.29 M(+2.0%) |
| June 2023 | - | -$416.11 M(+3.1%) |
| Mar 2023 | - | -$403.76 M(-3.5%) |
| Dec 2022 | -$418.50 M(+11.0%) | -$418.50 M(+6.3%) |
| Sept 2022 | - | -$393.59 M(-3.7%) |
| June 2022 | - | -$408.57 M(+3.3%) |
| Mar 2022 | - | -$395.45 M(+4.8%) |
| Dec 2021 | -$377.17 M(+12.7%) | -$377.17 M(+4.7%) |
| Sept 2021 | - | -$360.36 M(+5.3%) |
| June 2021 | - | -$342.28 M(-3.0%) |
| Mar 2021 | - | -$352.99 M(+5.5%) |
| Dec 2020 | -$334.70 M(+28.8%) | -$334.70 M(+6.9%) |
| Sept 2020 | - | -$313.07 M(+6.0%) |
| June 2020 | - | -$295.43 M(+6.6%) |
| Mar 2020 | - | -$277.13 M(+6.7%) |
| Dec 2019 | -$259.83 M | -$259.83 M(+5.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2019 | - | -$245.80 M(-1.2%) |
| June 2019 | - | -$248.84 M(+5.8%) |
| Mar 2019 | - | -$235.30 M(+7.6%) |
| Dec 2018 | -$218.74 M(+46.4%) | -$218.74 M(+6.0%) |
| Sept 2018 | - | -$206.39 M(+7.1%) |
| June 2018 | - | -$192.77 M(+16.0%) |
| Mar 2018 | - | -$166.14 M(+11.2%) |
| Dec 2017 | -$149.39 M(+59.5%) | -$149.39 M(+9.9%) |
| Sept 2017 | - | -$135.96 M(+9.9%) |
| June 2017 | - | -$123.70 M(+15.5%) |
| Mar 2017 | - | -$107.06 M(+14.3%) |
| Dec 2016 | -$93.66 M(+105.9%) | -$93.66 M(+18.2%) |
| Sept 2016 | - | -$79.27 M(+18.2%) |
| June 2016 | - | -$67.04 M(+21.3%) |
| Mar 2016 | - | -$55.29 M(+21.5%) |
| Dec 2015 | -$45.50 M(+242.0%) | -$45.50 M(+27.7%) |
| Sept 2015 | - | -$35.63 M(+34.7%) |
| June 2015 | - | -$26.45 M(+32.0%) |
| Mar 2015 | - | -$20.04 M(+50.6%) |
| Dec 2014 | -$13.30 M(+843.5%) | -$13.30 M |
| Dec 2013 | -$1.41 M | - |
FAQ
- What is Cidara Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Cidara Therapeutics?
- What is Cidara Therapeutics annual retained earnings year-on-year change?
- What is Cidara Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Cidara Therapeutics?
- What is Cidara Therapeutics quarterly retained earnings year-on-year change?
What is Cidara Therapeutics annual retained earnings?
The current annual retained earnings of CDTX is -$441.43 M
What is the all time high annual retained earnings for Cidara Therapeutics?
Cidara Therapeutics all-time high annual retained earnings is -$1.41 M
What is Cidara Therapeutics annual retained earnings year-on-year change?
Over the past year, CDTX annual retained earnings has changed by -$22.93 M (-5.48%)
What is Cidara Therapeutics quarterly retained earnings?
The current quarterly retained earnings of CDTX is -$558.95 M
What is the all time high quarterly retained earnings for Cidara Therapeutics?
Cidara Therapeutics all-time high quarterly retained earnings is -$13.30 M
What is Cidara Therapeutics quarterly retained earnings year-on-year change?
Over the past year, CDTX quarterly retained earnings has changed by -$134.66 M (-31.74%)